CONVERSION CHEMOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER: A CASE REPORT

CONVERSION CHEMOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER: A CASE REPORT

We present a case report of locally advanced colorectal cancer that responded successfully to conservation chemotherapy allowing R resection to be performed. Morphological characteristics prior to and after chemotherapy have been described in detail. This case report demonstrates the feasibility o...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. Z. Azanov, A. P. Koshel, S. V. Vtorushin, О. V. Zharkova, К. V. Vyalova, I. V. Vikhlyanov, N. Е. Verzhbitskaya, A. S. Lyakhov
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-12-01
Series:	Сибирский онкологический журнал
Subjects:	locally advanced rectal cancer conversion chemotherapy tumor regression
Online Access:	https://www.siboncoj.ru/jour/article/view/453
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy
by: Daigo Kobayashi, et al.
Published: (2018-09-01)

Short-term outcomes of preoperative chemotherapy in patients with upper ampullary rectal cancer
by: A. Yu. Dobrodeev, et al.
Published: (2022-01-01)

Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis
by: Yue Guo, et al.
Published: (2025-02-01)

Neoadjuvant chemotherapy versus long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of 5,168 cases
by: Wenjie Zhou, et al.
Published: (2025-06-01)

Correlation analysis of tertiary lymphoid structure parameters with the prognosis of patients with locally advanced rectal cancer after neoadjuvant chemotherapy: a retrospective study
by: Yingjian Jiang, et al.
Published: (2025-04-01)

MESENTERIC LYMPH NODES IN SIMULATED RECTAL CANCER UNDER CONDITIONS OF CHEMOTHERAPY
by: N. B. Isakova, et al.
Published: (2016-02-01)

Assessment of Immunoscore, MRI Tumor Regression Grade, and Neoadjuvant Rectal Score in Predicting Pathologic Response in Locally Advanced Rectal Cancer in the Averectal Study
by: Mustafa Natout, et al.
Published: (2025-04-01)

The Impact of Adjuvant Chemotherapy on Clinical Outcomes in Locally Advanced Rectal Cancer: A CHORD Consortium Analysis
by: Kaveh Farrokhi, et al.
Published: (2025-06-01)

Single centre experience with conversion surgery for advanced and metastatic gastric cancer in Slovakia
by: Július Palaj, et al.
Published: (2025-04-01)

[Comment] Clinical outcomes of ileostomy closure during versus after adjuvant chemotherapy in patients with rectal cancer
by: Zhao Zeyun, et al.
Published: (2024-06-01)

Safety and efficacy of individualized modified total neoadjuvant therapy for low locally advanced rectal cancer
by: Qing Ye, et al.
Published: (2025-07-01)

Predictors of pathological complete response after total neoadjuvant treatment using short course radiotherapy for locally advanced rectal cancer
by: Haythem Yacoub, et al.
Published: (2025-03-01)

mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemother apy in locally advanced rectal cancer:a propensity score matching analysis
by: Qiu Meng
Published: (2022-04-01)

Current application status of pelvic rrgan resection in locally advanced rectal cancer and local recurrent rectal cancer
by: Lu Li, et al.
Published: (2022-06-01)

Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancer
by: Alex Besson, et al.
Published: (2025-05-01)

Is there still a place for open surgery in the treatment strategy of rectal cancer?
by: Andrzej Kawiński, et al.
Published: (2018-12-01)

Radiotherapy versus no radiotherapy for rectal neuroendocrine carcinoma patients treated with surgery and chemotherapy: a population-based cohort study
by: Xiaojun Liu, et al.
Published: (2025-08-01)

Conversion surgery for initially unresectable carcinoma of the ampulla of Vater following pathological complete response to chemotherapy: a case report
by: Yo Sato, et al.
Published: (2019-07-01)

EGFR EXPRESSION IN RECTAL CANCER, RELATION TO THE FREAQUENCY OF LYMPH NODE METASTASIS
by: I. V. Stepanov, et al.
Published: (2017-06-01)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 study
by: Zhenyu Lin, et al.
Published: (2025-05-01)

Impact of the Timing of Protective Stoma Reversal on Survival in Rectal Cancer Patients Undergoing Postoperative Adjuvant Chemotherapy: A Retrospective Single Center Study
by: Wang J, et al.
Published: (2025-04-01)

The efficacy and safety of neoadjuvant and adjuvant chemo(radio)therapy combined with surgery in patients with locally advanced rectal cancer harboring defective mismatch repair system: a large-scale multicenter propensity score analysis
by: Huan-Huan Wang, et al.
Published: (2025-07-01)

Multi‐Institutional MR‐Derived Radiomics to Predict Post‐Exenteration Disease Recurrence in Patients With T4 Rectal Cancer
by: Niall J. O'Sullivan, et al.
Published: (2025-02-01)

Prognostic significance of preoperative CT-based sarcopenia in locally advanced rectal cancer: a multicenter retrospective study
by: Jiahong Zhu, et al.
Published: (2025-02-01)

Basic surgical principles for locally advanced rectal cancer in complex therapy
by: Yu. A. Barsukov, et al.
Published: (2024-11-01)

Neoadjuvant therapy in rectal cancer—one year follow-up results of standard versus total neoadjuvant strategies
by: Luís Correia Gomes, et al.
Published: (2024-11-01)

Longitudinal Measurements of Inflammatory Indices During Treatment for Locally Advanced Rectal Cancer and Associations with Smoking, Ethnicity and Pathological Response
by: Nancy Huang, et al.
Published: (2025-05-01)

Immediate results of neoadjuvant chemotherapy for resectable colon cancer
by: D. I. Azovsky, et al.
Published: (2025-03-01)

MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER
by: S. R. Altybaev, et al.
Published: (2016-11-01)

Immediate and long-term results of the treatment of patients with rectal cancer
by: O. I. Kit, et al.
Published: (2023-02-01)

Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
by: Rongxin Zhang, et al.
Published: (2025-08-01)

Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report
by: Kosuke Fukuda, et al.
Published: (2022-04-01)

Optimal Sequence for Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: An Evidence‐Based Review
by: Reza Ghalehtaki, et al.
Published: (2024-10-01)

Predictive value and changes of inducible nitric oxide synthase expression in patients with rectal cancer under the influence of antitumor therapy
by: V. V. Holotiuk, et al.
Published: (2018-09-01)

A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-08-01)

ASSESSMENT OF RECEPTOR CONVERSION ROLE FOR ADVANCED BREAST CANCER ON THE CHEMORESISTANCE OCCURRENCE
by: Oleksii V. Movchan, et al.
Published: (2025-03-01)

Prognostic Impact of the Postoperative Carcinoembryonic Antigen Level after Curative Resection of Locally Advanced Rectal Cancer
by: Ryoichi Tsukamoto, et al.
Published: (2025-01-01)

Successful conversion surgery for gastric cancer with multiple liver metastases treated after S-1 plus cisplatin combination chemotherapy: a case report
by: Masashi Tsunematsu, et al.
Published: (2017-08-01)

Radiomic Features of Mesorectal Fat as Indicators of Response in Rectal Cancer Patients Undergoing Neoadjuvant Therapy
by: Francesca Treballi, et al.
Published: (2025-04-01)

THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER
by: A. A. Bobryshev, et al.
Published: (2021-03-01)